Project Summary Filariasis is a group of neglected tropical diseases produced by infection with microfilaria of Clade III parasitic nematodes that ae transmitted by biting insects. River Blindness caused by Onchocerca volvulus, and Lymphatic Filariasis produced by Brugia malayi are examples of these diseases. River Blindness is caused by parasites that produce scaring of the cornea as well as severe itching and dermatitis; it infects 17 million people in West and Central Africa. Lymphatic filariasis is a debilitating and disfiguring disease, which occurs in 120 million people worldwide. Control of these nematode parasites relies on a small number of anthelmintic drugs, which have a limited spectrum of action. There are no practical macrofilaricides, which kill the adult parasites in the host; and there are concerns that mass microfilaricide chemotherapy will lead to the development of resistance. Diethylcarbamazine is a mainstay for the treatment of lymphatic filariasis in most parts of the world, except in areas where onchocerciasis is present because it is contra-indicated by risks of blindness. It produces rapid clearance of microfilaria and causes ~40% mortality of adult parasites (macrofilaricide). It is striking however, that 68 years after its introduction, we have no proven understanding of the molecular mechanism of its action. Here, we propose to re-invigorate this investigation by studying its effects on filarial ion-channels, including effects on SLO-1 K channels. Emodepside is an emerging and important cyclooctadepsipeptide class of anthelmintic that also has effects on microfilaria and adult filaria. Single emodepside treatments could allow a major advance over existing mass drug administration (MDA) programs which require regular treatments to kill adult parasites. One of the putative sites of action of emodepside is on nematode SLO-1 K channels where opening of the channels inhibits motility, but it is not effective against all filaria. Here we propose to examine filarial SLO-1 K channels as sites of action of emodepside. Our approach will focus on Brugia malayi but we will also use include studies on Onchocerca and human channels. We will use patch-clamp, dsRNA knock down, Worminator motility assays and Xenopus expression to characterize the functional properties of innate SLO-1 K channels from Brugia malayi. In Aim #1, we will test the hypothesis that Brugia malayi SLO-1 K channels are the only target sites of diethylcarbamazine and emodepside. We will use patch-clamp recordings of SLO-1 K channels from Brugia muscle cells and examine effects of knock down of putative targets. We propose, in , to express Onchocerca, human and Brugia SLO-1 K channels splice variants in Xenopus oocytes to test the hypothesis that different species of filaria and human SLO-1 K channels are pharmacologically separable using emodepside and K channel agonists. Aim #2 The proposal is innovative, using a combination of techniques to test the effects of ...